Rosacea
Conference Coverage
Oral sarecycline promising for papulopustular rosacea
“Always aim for clear skin.”
From the Journals
Vasodilatory medications found protective against rosacea
“We were very surprised to find that many of the agents we think of as vasodilators might actually be beneficial for rosacea.”
Conference Coverage
Energy-based devices: Expert shares treatment tips for rosacea, scars
For flat, red scars, vascular devices are the first choice.
Conference Coverage
Face masks can aggravate rosacea
The mask-aggravated rosacea, or “maskacea,” was mainly localized to the dorsal lower third of the nose as well as the cheeks.
From the Journals
Study results support screening rosacea patients for cardiometabolic disease
A meta-analysis of more than 50,000 patients shows increased prevalence of risk factors.
Conference Coverage
Moving from subtypes to phenotypes is simplifying management of rosacea
With the previous method of subtyping, many rosacea patients failed to fit neatly into any of the four categories, producing confusion and...
Conference Coverage
Role of lasers and light sources in medicine continue to expand
“We are seeing incredible capabilities with fiber lasers: essentially any wavelength, any power, any pulse duration you want.”
Conference Coverage
Treatment pipeline holds promise for rosacea
Recent studies of low-dose oral minocycline and topical encapsulated benzoyl peroxide show potential.
Cosmeceutical Critique
Dermatologists and the history of skin care and beauty devices: Part 4
Stiefel Laboratories worked with many dermatologists to help them develop their ideas. They included Cleveland White, MD, who patented a highly...
Commentary
Active Comparator Trial Designs Used to Promote Development of Innovative New Medications
Although some recent clinical trials in dermatology have included active comparators, many new medications continue to be introduced without any...
From the Journals
Review finds evidence for beta-blockers for some rosacea symptoms
A systematic review provides limited evidence to support oral beta-blockers as a treatment for rosacea-associated facial erythema and flushing.